Arbutus Biopharma Corp Stock Ownership - Who owns Arbutus Biopharma?

Insider buying vs selling

Have Arbutus Biopharma Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ABUS insiders and whales buy or sell their stock.

ABUS Shareholders

What type of owners hold Arbutus Biopharma Corp stock?
Roivant Sciences Ltd23.17%38,847,462$71.87MInsider
Dexxon Holdings Ltd19.10%32,027,080$59.25MInsider
Vivek Ramaswamy9.58%16,068,455$29.73MInsider
Andrew Lo9.55%16,013,540$29.63MInsider
Qvt Associates GP LLC9.55%16,013,540$29.63MInsider
Dexcel Pharma Technologies Ltd9.55%16,013,540$29.63MInsider
Rose Sharon Shabet9.55%16,013,540$29.63MInsider
Viking Global Performance LLC9.55%16,013,540$29.63MInsider
Svf Investments Uk Ltd9.55%16,013,540$29.63MInsider
Patrick MacHado9.55%16,013,540$29.63MInsider

1 of 3

ABUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
THRD73.23%26.77%Net Buying
CDMO91.78%8.22%Net SellingNet Buying
AURA71.84%21.39%Net BuyingNet Buying

Arbutus Biopharma Stock Ownership FAQ

Who owns Arbutus Biopharma?

Arbutus Biopharma (NASDAQ: ABUS) is owned by 42.20% institutional shareholders, 142.18% Arbutus Biopharma insiders, and 0.00% retail investors. Roivant Sciences Ltd is the largest individual Arbutus Biopharma shareholder, owning 38.85M shares representing 23.17% of the company. Roivant Sciences Ltd's Arbutus Biopharma shares are currently valued at $71.87M.

If you're new to stock investing, here's how to buy Arbutus Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.